Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting

<div>Impact of Control-IQ technology on glycemic outcomes. (a) Percent time in target range (3.9–10.0 mmol/L or 70–180 mg/dL) from baseline to the end of the study. (b) Percentage of participants meeting targets for time in range (TIR ≥70%) and glucose management indicator (GMI &lt;7.0%) from baseline to the end of the study.</div>

Pediatric Diabetes

fig2

Figure 2

Figure 2: Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting 

Figure 2 | Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting 